Patents by Inventor Nicolas Couvrat

Nicolas Couvrat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9487477
    Abstract: The present invention relates to a new crystalline phase of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and its use, particularly in the pharmaceutical industry, and to processes for preparation thereof. The invention is also directed to pharmaceutical compositions containing at least one crystalline phase of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and to the therapeutic or prophylactic use of such crystalline phase and compositions comprising the same.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: November 8, 2016
    Assignee: Quantum Genomics
    Inventors: Fabrice Balavoine, Jean-Marie Schneider, Gérard Coquerel, Nicolas Couvrat
  • Publication number: 20160221940
    Abstract: The present invention relates to a new crystalline phase of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and its use, particularly in the pharmaceutical industry, and to processes for preparation thereof. The invention is also directed to pharmaceutical compositions containing at least one crystalline phase of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and to the therapeutic or prophylactic use of such crystalline phase and compositions comprising the same.
    Type: Application
    Filed: February 1, 2016
    Publication date: August 4, 2016
    Inventors: Fabrice Balavoine, Jean-Marie Schneider, Gérard Coquerel, Nicolas Couvrat
  • Patent number: 9340497
    Abstract: The present invention relates to a new method for the preparation of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate A.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: May 17, 2016
    Assignee: QUANTUM GENOMICS
    Inventors: Fabrice Balavoine, Jonathan Madec, Jean-Marie Schneider, Gerard Coquerel, Nicolas Couvrat, Yohann Cartigny, Marie-Noelle Petit
  • Patent number: 9278921
    Abstract: The present invention relates to a new crystalline phase of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and its use, particularly in the pharmaceutical industry, and to processes for preparation thereof. The invention is also directed to pharmaceutical compositions containing at least one crystalline phase of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and to the therapeutic or prophylactic use of such crystalline phase and compositions comprising the same.
    Type: Grant
    Filed: October 22, 2013
    Date of Patent: March 8, 2016
    Assignee: Quantum Genomics
    Inventors: Fabrice Balavoine, Jean-Marie Schneider, Gérard Coquerel, Nicolas Couvrat
  • Publication number: 20160046571
    Abstract: The present invention relates to a new method for the preparation of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate A.
    Type: Application
    Filed: October 27, 2015
    Publication date: February 18, 2016
    Inventors: Fabrice BALAVOINE, Jonathan MADEC, Jean-Marie SCHNEIDER, Gerard COQUEREL, Nicolas COUVRAT, Yohann CARTIGNY, Marie-Noelle PETIT
  • Patent number: 9187418
    Abstract: The present invention relates to a new method for the preparation of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate A.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: November 17, 2015
    Assignee: QUANTUM GENOMICS
    Inventors: Fabrice Balavoine, Jonathan Madec, Jean-Marie Schneider, Gérard Coquerel, Nicolas Couvrat, Yohann Cartigny, Marie-Noëlle Petit
  • Publication number: 20150284325
    Abstract: The present invention relates to a new crystalline phase of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and its use, particularly in the pharmaceutical industry, and to processes for preparation thereof. The invention is also directed to pharmaceutical compositions containing at least one crystalline phase of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) (ABSD) with L-lysine and to the therapeutic or prophylactic use of such crystalline phase and compositions comprising the same.
    Type: Application
    Filed: October 22, 2013
    Publication date: October 8, 2015
    Applicant: Quantum Genomics
    Inventors: Fabrice Balavoine, Jean-Marie Schneider, Gérard Coquerel, Nicolas Couvrat
  • Publication number: 20130231500
    Abstract: The present invention relates to a new method for the preparation of (3S,3S?) 4,4?-disulfanediylbis(3-aminobutane 1-sulfonic acid) in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate A.
    Type: Application
    Filed: October 7, 2011
    Publication date: September 5, 2013
    Applicant: QUANTUM GEOMICS
    Inventors: Fabrice Balavoine, Jonathan Madec, Jean-Marie Schneider, Gérard Coquerel, Nicolas Couvrat, Yohann Cartigny, Marie-Noëlle Petit